title: Ocular manifestations in a case of childhood cicatricial pemphigoid.
abstract: OBJECTIVE
  Cicatricial pemphigoid is a rare chronic autoimmune disease, characterized by progressive alterations on the skin and mucous membranes. Ocular lesions consists of chronic conjunctivitis, progressive subepithelial fibrosis on the conjunctival fornix together with symblepharon formation, obstruction of the Meibomian ducts, sicca syndrome, and occasionally, entropion associated with consequent trichiasis and corneal ulcers.
  
  
  METHODS
  A 9-year-old patient with cicatricial pemphigoid with severe eye involvement came to our observation. A complete anamnesis, ophthalmologic examination, and systemic evaluation, including serum antibody levels evaluation and biopsies of mouth, vulva, parotid, and intestine mucosa, were performed.
  
  
  RESULTS
  Ocular examination showed blepharospasm, conjunctival hyperemia, symblepharon, total cicatricial corneal leucoma, severe dryness, trichiasis, and eyelid edema. The results of medical and surgical treatment are reported.
  
  
  CONCLUSIONS
  Given the serious clinical picture, possibly due to a late diagnosis, it was not possible to avoid relapse and appearance of new cicatricial adherences for which we considered wait and see the most appropriate approach, protecting the anterior segment of both eyes, sacrificing their function. Further follow-up was not possible as the patient died. An early diagnosis would have had a significant influence on the clinical course and on the response to therapy.
authors.affiliation: Department of Ophthalmology, University of Napoli Federico II, Napoli, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Iovine
authors.forename: F
authors.initials: F
authors.lastname: Fimiani
authors.forename: P
authors.initials: P
authors.lastname: Vassallo
authors.forename: M
authors.initials: M
authors.lastname: Alessio
authors.forename: A
authors.initials: A
authors.lastname: Magli
mesh_terms: D000974:Antibodies, Antinuclear / Q000097:blood; D001764:Blepharospasm / Q000175:diagnosis* / Q000628:therapy; D002648:Child; D003131:Combined Modality Therapy; D003231:Conjunctivitis / Q000175:diagnosis* / Q000628:therapy; D003318:Corneal Opacity / Q000175:diagnosis* / Q000628:therapy; D004247:DNA / Q000276:immunology; D015352:Dry Eye Syndromes / Q000175:diagnosis* / Q000628:therapy; D005140:Eyelashes / Q000473:pathology; D017809:Fatal Outcome; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006201:Hair Diseases / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D013508:Ophthalmologic Surgical Procedures; D010390:Pemphigoid, Benign Mucous Membrane / Q000175:diagnosis* / Q000628:therapy; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D000974:Antibodies, Antinuclear; D005938:Glucocorticoids; D004247:DNA; D011241:Prednisone